Top Markets
#1 TENDIES TENDIES +30.30%
#2 ICON ICON +26.40%
#3 Cash Cat Cash Cat +25.78%
#4 Threshold Network Threshold Network +20.88%
#5 OSK OSK +15.83%
#6 Ape and Pepe Ape and Pepe +12.62%
#7 Asteroid Shiba Asteroid Shiba +12.53%
#8 Magma Finance Magma Finance +11.91%
#9 龙虾 (Lobster) 龙虾 (Lobster) +10.84%
#10 Kite Kite +10.78%
Coin of the day
TENDIES TENDIES
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
NervGen Pharma Corp. NervGen Pharma Corp.

NervGen Pharma Corp.

NGEN
Pozycja w akcjach #16730
NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical... NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical company dedicated to discovering, advancing, and commercializing innovative drug therapies for neurological conditions involving nerve damage. Its flagship investigational therapy, NVG-291, is currently undergoing Phase 1 clinical trials, targeting significant neurological disorders such as spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. NervGen has also secured an exclusive licensing agreement with Case Western Reserve University. This partnership enables the company to research, advance, and commercialize a proprietary technology holding considerable therapeutic promise for SCI and a range of other nerve-related ailments. Established in 2017, NervGen Pharma Corp. maintains its headquarters in Vancouver, Canada.
Cena akcji
$3.78
Ostatnia synchronizacja: 2026-03-17
Kapitalizacja rynkowa
$276.54M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
45.53%
Kraj
CA
Handel NervGen Pharma Corp. (NGEN)

Kategoria

Healthcare
Zyski dla NervGen Pharma Corp. (NGEN)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych NervGen Pharma Corp., obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy NervGen Pharma Corp. od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH